• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CMB 0.00% 38.0¢

CAMBIUM BIO LIMITED - Announcements

Cambium Bio Limited, formerly Regeneus Ltd, is an Australia-based clinical-stage... Cambium Bio Limited, formerly Regeneus Ltd, is an Australia-based clinical-stage regenerative medicine company focusing on the development of biologics for ophthalmology and tissue repair applications. Its technology, based on human platelet lysate, is being leveraged to create a pipeline of novel therapeutics, with a primary focus on ophthalmology. Its lead product candidate, Elate Ocular, is being developed to address significant unmet medical needs in the treatment of dry eye disease. Elate Ocular is formulated from the processing of base human platelets sourced not from patients, but generally healthier younger eligible donors at U.S. blood collection centers. In addition, its stem cell platform, Progenza, is being applied to the development of therapies for knee osteoarthritis and other tissue repair indications. It also manufactures and sells stem cell growth supplements, such as UltraGRO Advanced, UltraGRO Pure (xeno-free), and UltraGRO Pure GI (xeno-free, gamma irradiated).More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


Filters [Clear]
  • Price Sensitive: Yes
CMB Cambium 4E and Annual ReportPRICE SENSITIVE30/08/24 download Created with Sketch. 3.52MB
CMB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/07/24 download Created with Sketch. 284.86KB
CMB Notice of General Meeting/Proxy FormPRICE SENSITIVE23/05/24 download Created with Sketch. 2.04MB
CMB Response to ASX Aware QueryPRICE SENSITIVE01/05/24 download Created with Sketch. 800.58KB
CMB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE30/04/24 download Created with Sketch. 339.14KB
CMB Cambium Bio Raises A$3.48 Million in Strategic PlacementPRICE SENSITIVE05/04/24 download Created with Sketch. 170.74KB
CMB Regeneus Completes the Merger with CambiumPRICE SENSITIVE05/04/24 download Created with Sketch. 163.7KB
CMB Half Yearly Report and AccountsPRICE SENSITIVE29/02/24 download Created with Sketch. 1.3MB
CMB Regeneus enters into binding merger agreement with CambiumPRICE SENSITIVE14/02/24 download Created with Sketch. 150.87KB
CMB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/01/24 download Created with Sketch. 294.12KB
CMB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/10/23 download Created with Sketch. 290.95KB
CMB Cambium Bio - Shareholder Update presentationPRICE SENSITIVE28/09/23 download Created with Sketch. 2.5MB
CMB Appendix 4E - Preliminary final report-unauditedPRICE SENSITIVE31/08/23 download Created with Sketch. 267.38KB
CMB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/07/23 download Created with Sketch. 349.88KB
CMB Response to ASX Price QueryPRICE SENSITIVE06/07/23 download Created with Sketch. 256.03KB
CMB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE28/04/23 download Created with Sketch. 407.48KB
CMB Merger with CambiumPRICE SENSITIVE28/04/23 download Created with Sketch. 161.91KB
CMB Half Yearly Report and AccountsPRICE SENSITIVE28/02/23 download Created with Sketch. 1.7MB
CMB Regeneus agrees to settle $2m loanPRICE SENSITIVE28/02/23 download Created with Sketch. 137.23KB
CMB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/01/23 download Created with Sketch. 398.91KB
CMB Notice of Termination of Kyocera LicencePRICE SENSITIVE31/01/23 download Created with Sketch. 138.71KB
CMB Trading HaltPRICE SENSITIVE30/01/23 download Created with Sketch. 174KB
CMB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE28/10/22 download Created with Sketch. 366.6KB
CMB Preliminary Final ReportPRICE SENSITIVE30/08/22 download Created with Sketch. 2.48MB
CMB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE21/07/22 download Created with Sketch. 388.17KB
CMB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE29/04/22 download Created with Sketch. 396.68KB
CMB Half Yearly Report and AccountsPRICE SENSITIVE25/02/22 download Created with Sketch. 1.54MB
CMB Grant of ASX WaiverPRICE SENSITIVE25/02/22 download Created with Sketch. 161.87KB
CMB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE28/01/22 download Created with Sketch. 396.89KB
CMB Regeneus Market UpdatePRICE SENSITIVE22/12/21 download Created with Sketch. 149.53KB
CMB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE29/10/21 download Created with Sketch. 372.82KB
CMB Appendix 4E - Preliminary final report-unauditedPRICE SENSITIVE31/08/21 download Created with Sketch. 1.04MB
CMB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE29/07/21 download Created with Sketch. 320.85KB
CMB Regeneus Announces Institutional PlacementPRICE SENSITIVE07/05/21 download Created with Sketch. 152.62KB
CMB Appendix 4C - QuarterlyPRICE SENSITIVE30/04/21 download Created with Sketch. 323.77KB
CMB Regeneus partners with Defence to treat combat casualtiesPRICE SENSITIVE29/04/21 download Created with Sketch. 144KB
CMB Regeneus to be granted key Progenza patent in EuropePRICE SENSITIVE16/03/21 download Created with Sketch. 155.15KB
CMB Regeneus Company Update Investor Webcast PresentationPRICE SENSITIVE03/03/21 download Created with Sketch. 1.16MB
CMB Half-Year Results and Business UpdatePRICE SENSITIVE26/02/21 download Created with Sketch. 166.9KB
CMB Appendix 4D and Half-Year ReportPRICE SENSITIVE26/02/21 download Created with Sketch. 1.13MB
CMB Regeneus to be granted new patent to target pain in JapanPRICE SENSITIVE09/02/21 download Created with Sketch. 146.19KB
CMB Response to ASX Appendix 4C QueryPRICE SENSITIVE05/02/21 download Created with Sketch. 325.12KB
CMB Appendix 4C - Quarterly ReportPRICE SENSITIVE29/01/21 download Created with Sketch. 317.22KB
CMB Clarification on Quarterly Activity Report and Appendix 4CPRICE SENSITIVE11/11/20 download Created with Sketch. 123.12KB
CMB CEO Appointment and ResignationPRICE SENSITIVE02/11/20 download Created with Sketch. 126KB
CMB Appendix 4C - QuarterlyPRICE SENSITIVE30/10/20 download Created with Sketch. 318.66KB
CMB Regeneus receives $5.6M milestone payment from KyoceraPRICE SENSITIVE29/10/20 download Created with Sketch. 122.45KB
CMB Regeneus to be granted new Sygenus patent in CanadaPRICE SENSITIVE07/10/20 download Created with Sketch. 135.28KB
CMB Regeneus receives milestone payment from KyoceraPRICE SENSITIVE28/08/20 download Created with Sketch. 131.33KB
CMB Appendix 4E and Annual ReportPRICE SENSITIVE28/08/20 download Created with Sketch. 1.51MB
CMB Regeneus to present at FNN Virtual Investor EventPRICE SENSITIVE25/08/20 download Created with Sketch. 1.42MB
CMB US Patent for SygenusPRICE SENSITIVE19/08/20 download Created with Sketch. 137.03KB
CMB Regeneus and Kyocera sign Progenza OA dealPRICE SENSITIVE11/08/20 download Created with Sketch. 184.71KB
CMB Trading HaltPRICE SENSITIVE07/08/20 download Created with Sketch. 147.71KB
CMB Appendix 4C - QuarterlyPRICE SENSITIVE31/07/20 download Created with Sketch. 300.13KB
CMB Progenza OA Kyocera negotiations updatePRICE SENSITIVE28/07/20 download Created with Sketch. 111.68KB
CMB Kyocera completes Progenza Due DiligencePRICE SENSITIVE18/05/20 download Created with Sketch. 125.44KB
CMB Appendix 4C UpdatedPRICE SENSITIVE05/05/20 download Created with Sketch. 303.19KB
CMB Appendix 4C - QuarterlyPRICE SENSITIVE29/04/20 download Created with Sketch. 296.66KB
CMB Regeneus to be granted new key Progenza patent in U.S.PRICE SENSITIVE23/03/20 download Created with Sketch. 151.7KB
CMB Regeneus receives A$1.6M milestone payment from KyoceraPRICE SENSITIVE20/03/20 download Created with Sketch. 133.92KB
CMB Regeneus signs MOU with Kyocera CorporationPRICE SENSITIVE02/03/20 download Created with Sketch. 158.67KB
CMB Half-Year Results & Business UpdatePRICE SENSITIVE28/02/20 download Created with Sketch. 181.02KB
CMB Appendix 4D and Half-Year ReportPRICE SENSITIVE28/02/20 download Created with Sketch. 1.17MB
CMB Directors provide $4m loan facilityPRICE SENSITIVE28/02/20 download Created with Sketch. 179.4KB
CMB Appendix 4C - QuarterlyPRICE SENSITIVE31/01/20 download Created with Sketch. 313.26KB
CMB AGC Agreement termination paves way for commercial partnerPRICE SENSITIVE20/12/19 download Created with Sketch. 172.04KB
CMB CEO Presentation to 2019 Annual General MeetingPRICE SENSITIVE21/11/19 download Created with Sketch. 819.25KB
CMB Chairman's Address to ShareholdersPRICE SENSITIVE21/11/19 download Created with Sketch. 66.33KB
CMB Japanese Biotech Fund takes up all Rights Issue ShortfallPRICE SENSITIVE19/11/19 download Created with Sketch. 135.62KB
CMB Response to ASX Appendix 4C QueryPRICE SENSITIVE31/10/19 download Created with Sketch. 1005.4KB
CMB Appendix 4C - QuarterlyPRICE SENSITIVE31/10/19 download Created with Sketch. 297.16KB
CMB Regeneus receives A$1.5 million in R&D Tax IncentivesPRICE SENSITIVE15/10/19 download Created with Sketch. 99.45KB
CMB Appendix 4EPRICE SENSITIVE30/08/19 download Created with Sketch. 306.59KB
CMB Restructuring results in 50% reduction in operating costsPRICE SENSITIVE13/08/19 download Created with Sketch. 129.96KB
CMB Updated Investor PresentationPRICE SENSITIVE07/08/19 download Created with Sketch. 612.85KB
CMB Offer BookletPRICE SENSITIVE01/08/19 download Created with Sketch. 1.31MB
CMB Investor PresentationPRICE SENSITIVE01/08/19 download Created with Sketch. 624.27KB
CMB Successful Private PlacementPRICE SENSITIVE01/08/19 download Created with Sketch. 125.64KB
CMB Appendix 4C - QuarterlyPRICE SENSITIVE31/07/19 download Created with Sketch. 224.56KB
CMB Trading HaltPRICE SENSITIVE30/07/19 download Created with Sketch. 378.14KB
CMB Positive results for Progenza in treating neuropathic painPRICE SENSITIVE23/07/19 download Created with Sketch. 143.49KB
CMB Appendix 4C - QuarterlyPRICE SENSITIVE11/04/19 download Created with Sketch. 438.84KB
CMB Appendix 4D and Half-Year ReportPRICE SENSITIVE28/02/19 download Created with Sketch. 1.34MB
CMB Directors Provide $2.5M Loan to Extend Funding RunwayPRICE SENSITIVE28/02/19 download Created with Sketch. 65KB
CMB Response to ASX Appendix 4C Query LetterPRICE SENSITIVE22/02/19 download Created with Sketch. 657.35KB
CMB Appendix 4C - QuarterlyPRICE SENSITIVE30/01/19 download Created with Sketch. 239.42KB
CMB New CEO Appointed to Accelerate Global GrowthPRICE SENSITIVE23/01/19 download Created with Sketch. 69.59KB
CMB Chinese patent granted for biomarkers for stem cell therapyPRICE SENSITIVE03/12/18 download Created with Sketch. 77.36KB
CMB Re-Released - Appendix 4C - QuarterlyPRICE SENSITIVE24/10/18 download Created with Sketch. 231.27KB
CMB Progenza patent to grant in EuropePRICE SENSITIVE18/10/18 download Created with Sketch. 95.2KB
CMB Regeneus receives R&D tax incentive refund of $2.4mPRICE SENSITIVE06/09/18 download Created with Sketch. 103.36KB
CMB Appendix 4EPRICE SENSITIVE30/08/18 download Created with Sketch. 880.49KB
CMB Positive clinical trial results for cancer vaccinePRICE SENSITIVE30/07/18 download Created with Sketch. 125.95KB
CMB Appendix 4C - QuarterlyPRICE SENSITIVE25/07/18 download Created with Sketch. 224.84KB
CMB Response to ASX Price QueryPRICE SENSITIVE23/07/18 download Created with Sketch. 985.56KB
CMB US Patent Office to allow key patent for ProgenzaPRICE SENSITIVE10/07/18 download Created with Sketch. 104.26KB
CMB Update on licensing Progenza in JapanPRICE SENSITIVE03/07/18 download Created with Sketch. 99.81KB
CMB Grant of ASX WaiverPRICE SENSITIVE28/06/18 download Created with Sketch. 166.21KB
CMB Appendix 4C - QuarterlyPRICE SENSITIVE26/04/18 download Created with Sketch. 3.27MB
CMB Cambium 4E and Annual Report
30/08/24PRICE SENSITIVE download Created with Sketch. 3.52MB
CMB Quarterly Activities/Appendix 4C Cash Flow Report
31/07/24PRICE SENSITIVE download Created with Sketch. 284.86KB
CMB Notice of General Meeting/Proxy Form
23/05/24PRICE SENSITIVE download Created with Sketch. 2.04MB
CMB Response to ASX Aware Query
01/05/24PRICE SENSITIVE download Created with Sketch. 800.58KB
CMB Quarterly Activities/Appendix 4C Cash Flow Report
30/04/24PRICE SENSITIVE download Created with Sketch. 339.14KB
CMB Cambium Bio Raises A$3.48 Million in Strategic Placement
05/04/24PRICE SENSITIVE download Created with Sketch. 170.74KB
CMB Regeneus Completes the Merger with Cambium
05/04/24PRICE SENSITIVE download Created with Sketch. 163.7KB
CMB Half Yearly Report and Accounts
29/02/24PRICE SENSITIVE download Created with Sketch. 1.3MB
CMB Regeneus enters into binding merger agreement with Cambium
14/02/24PRICE SENSITIVE download Created with Sketch. 150.87KB
CMB Quarterly Activities/Appendix 4C Cash Flow Report
31/01/24PRICE SENSITIVE download Created with Sketch. 294.12KB
CMB Quarterly Activities/Appendix 4C Cash Flow Report
31/10/23PRICE SENSITIVE download Created with Sketch. 290.95KB
CMB Cambium Bio - Shareholder Update presentation
28/09/23PRICE SENSITIVE download Created with Sketch. 2.5MB
CMB Appendix 4E - Preliminary final report-unaudited
31/08/23PRICE SENSITIVE download Created with Sketch. 267.38KB
CMB Quarterly Activities/Appendix 4C Cash Flow Report
31/07/23PRICE SENSITIVE download Created with Sketch. 349.88KB
CMB Response to ASX Price Query
06/07/23PRICE SENSITIVE download Created with Sketch. 256.03KB
CMB Quarterly Activities/Appendix 4C Cash Flow Report
28/04/23PRICE SENSITIVE download Created with Sketch. 407.48KB
CMB Merger with Cambium
28/04/23PRICE SENSITIVE download Created with Sketch. 161.91KB
CMB Half Yearly Report and Accounts
28/02/23PRICE SENSITIVE download Created with Sketch. 1.7MB
CMB Regeneus agrees to settle $2m loan
28/02/23PRICE SENSITIVE download Created with Sketch. 137.23KB
CMB Quarterly Activities/Appendix 4C Cash Flow Report
31/01/23PRICE SENSITIVE download Created with Sketch. 398.91KB
CMB Notice of Termination of Kyocera Licence
31/01/23PRICE SENSITIVE download Created with Sketch. 138.71KB
CMB Trading Halt
30/01/23PRICE SENSITIVE download Created with Sketch. 174KB
CMB Quarterly Activities/Appendix 4C Cash Flow Report
28/10/22PRICE SENSITIVE download Created with Sketch. 366.6KB
CMB Preliminary Final Report
30/08/22PRICE SENSITIVE download Created with Sketch. 2.48MB
CMB Quarterly Activities/Appendix 4C Cash Flow Report
21/07/22PRICE SENSITIVE download Created with Sketch. 388.17KB
CMB Quarterly Activities/Appendix 4C Cash Flow Report
29/04/22PRICE SENSITIVE download Created with Sketch. 396.68KB
CMB Half Yearly Report and Accounts
25/02/22PRICE SENSITIVE download Created with Sketch. 1.54MB
CMB Grant of ASX Waiver
25/02/22PRICE SENSITIVE download Created with Sketch. 161.87KB
CMB Quarterly Activities/Appendix 4C Cash Flow Report
28/01/22PRICE SENSITIVE download Created with Sketch. 396.89KB
CMB Regeneus Market Update
22/12/21PRICE SENSITIVE download Created with Sketch. 149.53KB
CMB Quarterly Activities/Appendix 4C Cash Flow Report
29/10/21PRICE SENSITIVE download Created with Sketch. 372.82KB
CMB Appendix 4E - Preliminary final report-unaudited
31/08/21PRICE SENSITIVE download Created with Sketch. 1.04MB
CMB Quarterly Activities/Appendix 4C Cash Flow Report
29/07/21PRICE SENSITIVE download Created with Sketch. 320.85KB
CMB Regeneus Announces Institutional Placement
07/05/21PRICE SENSITIVE download Created with Sketch. 152.62KB
CMB Appendix 4C - Quarterly
30/04/21PRICE SENSITIVE download Created with Sketch. 323.77KB
CMB Regeneus partners with Defence to treat combat casualties
29/04/21PRICE SENSITIVE download Created with Sketch. 144KB
CMB Regeneus to be granted key Progenza patent in Europe
16/03/21PRICE SENSITIVE download Created with Sketch. 155.15KB
CMB Regeneus Company Update Investor Webcast Presentation
03/03/21PRICE SENSITIVE download Created with Sketch. 1.16MB
CMB Half-Year Results and Business Update
26/02/21PRICE SENSITIVE download Created with Sketch. 166.9KB
CMB Appendix 4D and Half-Year Report
26/02/21PRICE SENSITIVE download Created with Sketch. 1.13MB
CMB Regeneus to be granted new patent to target pain in Japan
09/02/21PRICE SENSITIVE download Created with Sketch. 146.19KB
CMB Response to ASX Appendix 4C Query
05/02/21PRICE SENSITIVE download Created with Sketch. 325.12KB
CMB Appendix 4C - Quarterly Report
29/01/21PRICE SENSITIVE download Created with Sketch. 317.22KB
CMB Clarification on Quarterly Activity Report and Appendix 4C
11/11/20PRICE SENSITIVE download Created with Sketch. 123.12KB
CMB CEO Appointment and Resignation
02/11/20PRICE SENSITIVE download Created with Sketch. 126KB
CMB Appendix 4C - Quarterly
30/10/20PRICE SENSITIVE download Created with Sketch. 318.66KB
CMB Regeneus receives $5.6M milestone payment from Kyocera
29/10/20PRICE SENSITIVE download Created with Sketch. 122.45KB
CMB Regeneus to be granted new Sygenus patent in Canada
07/10/20PRICE SENSITIVE download Created with Sketch. 135.28KB
CMB Regeneus receives milestone payment from Kyocera
28/08/20PRICE SENSITIVE download Created with Sketch. 131.33KB
CMB Appendix 4E and Annual Report
28/08/20PRICE SENSITIVE download Created with Sketch. 1.51MB
CMB Regeneus to present at FNN Virtual Investor Event
25/08/20PRICE SENSITIVE download Created with Sketch. 1.42MB
CMB US Patent for Sygenus
19/08/20PRICE SENSITIVE download Created with Sketch. 137.03KB
CMB Regeneus and Kyocera sign Progenza OA deal
11/08/20PRICE SENSITIVE download Created with Sketch. 184.71KB
CMB Trading Halt
07/08/20PRICE SENSITIVE download Created with Sketch. 147.71KB
CMB Appendix 4C - Quarterly
31/07/20PRICE SENSITIVE download Created with Sketch. 300.13KB
CMB Progenza OA Kyocera negotiations update
28/07/20PRICE SENSITIVE download Created with Sketch. 111.68KB
CMB Kyocera completes Progenza Due Diligence
18/05/20PRICE SENSITIVE download Created with Sketch. 125.44KB
CMB Appendix 4C Updated
05/05/20PRICE SENSITIVE download Created with Sketch. 303.19KB
CMB Appendix 4C - Quarterly
29/04/20PRICE SENSITIVE download Created with Sketch. 296.66KB
CMB Regeneus to be granted new key Progenza patent in U.S.
23/03/20PRICE SENSITIVE download Created with Sketch. 151.7KB
CMB Regeneus receives A$1.6M milestone payment from Kyocera
20/03/20PRICE SENSITIVE download Created with Sketch. 133.92KB
CMB Regeneus signs MOU with Kyocera Corporation
02/03/20PRICE SENSITIVE download Created with Sketch. 158.67KB
CMB Half-Year Results & Business Update
28/02/20PRICE SENSITIVE download Created with Sketch. 181.02KB
CMB Appendix 4D and Half-Year Report
28/02/20PRICE SENSITIVE download Created with Sketch. 1.17MB
CMB Directors provide $4m loan facility
28/02/20PRICE SENSITIVE download Created with Sketch. 179.4KB
CMB Appendix 4C - Quarterly
31/01/20PRICE SENSITIVE download Created with Sketch. 313.26KB
CMB AGC Agreement termination paves way for commercial partner
20/12/19PRICE SENSITIVE download Created with Sketch. 172.04KB
CMB CEO Presentation to 2019 Annual General Meeting
21/11/19PRICE SENSITIVE download Created with Sketch. 819.25KB
CMB Chairman's Address to Shareholders
21/11/19PRICE SENSITIVE download Created with Sketch. 66.33KB
CMB Japanese Biotech Fund takes up all Rights Issue Shortfall
19/11/19PRICE SENSITIVE download Created with Sketch. 135.62KB
CMB Response to ASX Appendix 4C Query
31/10/19PRICE SENSITIVE download Created with Sketch. 1005.4KB
CMB Appendix 4C - Quarterly
31/10/19PRICE SENSITIVE download Created with Sketch. 297.16KB
CMB Regeneus receives A$1.5 million in R&D Tax Incentives
15/10/19PRICE SENSITIVE download Created with Sketch. 99.45KB
CMB Appendix 4E
30/08/19PRICE SENSITIVE download Created with Sketch. 306.59KB
CMB Restructuring results in 50% reduction in operating costs
13/08/19PRICE SENSITIVE download Created with Sketch. 129.96KB
CMB Updated Investor Presentation
07/08/19PRICE SENSITIVE download Created with Sketch. 612.85KB
CMB Offer Booklet
01/08/19PRICE SENSITIVE download Created with Sketch. 1.31MB
CMB Investor Presentation
01/08/19PRICE SENSITIVE download Created with Sketch. 624.27KB
CMB Successful Private Placement
01/08/19PRICE SENSITIVE download Created with Sketch. 125.64KB
CMB Appendix 4C - Quarterly
31/07/19PRICE SENSITIVE download Created with Sketch. 224.56KB
CMB Trading Halt
30/07/19PRICE SENSITIVE download Created with Sketch. 378.14KB
CMB Positive results for Progenza in treating neuropathic pain
23/07/19PRICE SENSITIVE download Created with Sketch. 143.49KB
CMB Appendix 4C - Quarterly
11/04/19PRICE SENSITIVE download Created with Sketch. 438.84KB
CMB Appendix 4D and Half-Year Report
28/02/19PRICE SENSITIVE download Created with Sketch. 1.34MB
CMB Directors Provide $2.5M Loan to Extend Funding Runway
28/02/19PRICE SENSITIVE download Created with Sketch. 65KB
CMB Response to ASX Appendix 4C Query Letter
22/02/19PRICE SENSITIVE download Created with Sketch. 657.35KB
CMB Appendix 4C - Quarterly
30/01/19PRICE SENSITIVE download Created with Sketch. 239.42KB
CMB New CEO Appointed to Accelerate Global Growth
23/01/19PRICE SENSITIVE download Created with Sketch. 69.59KB
CMB Chinese patent granted for biomarkers for stem cell therapy
03/12/18PRICE SENSITIVE download Created with Sketch. 77.36KB
CMB Re-Released - Appendix 4C - Quarterly
24/10/18PRICE SENSITIVE download Created with Sketch. 231.27KB
CMB Progenza patent to grant in Europe
18/10/18PRICE SENSITIVE download Created with Sketch. 95.2KB
CMB Regeneus receives R&D tax incentive refund of $2.4m
06/09/18PRICE SENSITIVE download Created with Sketch. 103.36KB
CMB Appendix 4E
30/08/18PRICE SENSITIVE download Created with Sketch. 880.49KB
CMB Positive clinical trial results for cancer vaccine
30/07/18PRICE SENSITIVE download Created with Sketch. 125.95KB
CMB Appendix 4C - Quarterly
25/07/18PRICE SENSITIVE download Created with Sketch. 224.84KB
CMB Response to ASX Price Query
23/07/18PRICE SENSITIVE download Created with Sketch. 985.56KB
CMB US Patent Office to allow key patent for Progenza
10/07/18PRICE SENSITIVE download Created with Sketch. 104.26KB
CMB Update on licensing Progenza in Japan
03/07/18PRICE SENSITIVE download Created with Sketch. 99.81KB
CMB Grant of ASX Waiver
28/06/18PRICE SENSITIVE download Created with Sketch. 166.21KB
CMB Appendix 4C - Quarterly
26/04/18PRICE SENSITIVE download Created with Sketch. 3.27MB
(20min delay)
Last
38.0¢
Change
0.000(0.00%)
Mkt cap ! $4.533M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 2623 33.5¢
 

Sellers (Offers)

Price($) Vol. No.
37.5¢ 40 1
View Market Depth
Last trade - 10.02am 18/09/2024 (20 minute delay) ?
CMB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.